Notification of Release of Restricted Share in Escrow
other announcement
Latest articles and price-sensitive announcements with AI sentiment classification.
other announcement
other announcement
other announcement
Highlights The fertility services provider advanced again as the market digested its full year numbers. Several research desks refreshed their ratings following the result release. Health care was the only defensive sector to finish ahead on the session. Monash IVF Group Limited (ASX:MVF) extended its post-result bounce on Tuesday as the market continued absorbing full year numbers released the previous session, with several research desks refreshing their views and lifting a fertility servic...
Highlights The fertility services group reported a sharp fall in annual profit, landing beneath its own revised guidance range for the year. Softer domestic stimulated cycle volumes drove the shortfall, partly offset by growth across international, genetics and ancillary revenue streams. A final fully franked distribution was declared, and corporate interest in the company remains an unresolved thread in the story. Monash IVF Group (ASX:MVF), the Melbourne-headquartered fertility services pro...
Highlights Monash IVF reported a sharp fall in annual profit, landing beneath its revised guidance range. Offshore revenue and specialist genetics testing delivered record contributions across the year. Domestic stimulated cycle volumes steadied in the second half after a soft opening stretch. Monash IVF Group (ASX:MVF), the listed fertility services operator with clinics across Australia and South-East Asia, closed out the annual reporting calendar with a result that fell short of its own re...

Assisted reproduction leader Monash IVF fell short of full-year guidance, but reports of a second-half turnaround buoyed investors. ... Read More The post Health Check: Monash IVF misses profit guidance, but promises a rebirth appeared first on Stockhead.
Monash IVF Group Limited (ASX:MVF) has filed its Appendix 4G Key to Disclosures document with the ASX for the financial year ending 30 June 2026, confirming that the company's corporate governance statement was board-approved and remains accurate as of 21 August 2026. Key Points Monash IVF Group submitted its Appendix 4G for FY ended 30 June 2026 The corporate governance statement is available on the company website and received board approval as of 21 August 2026 Rebecca Dean, Company Secret...
Monash IVF (ASX:MVF) H2 Recovery Could Turn FY27 Into a Cash Flow Story Stocks Down Under

The company posted weaker FY26 profit but ends year with improving momentum, dividend, and outlook for growth. The post Monash IVF Group earnings: FY26 profit slips, outlook improves appeared first on The Motley Fool Australia.
other announcement
Monash IVF Group (ASX:MVF) Stock Is Falling — What's Driving the Drop? Kalkine
other announcement
Monash IVF (ASX:MVF) Fields a Fresh Takeover Offer—Will the Fertility Pioneer Say Yes? Kalkine
Monash IVF (ASX:MVF) Shares Tick Higher While Long-Term Performance Remains Under Pressure Kalkine
Highlights Monash IVF recently updated its earnings outlook following softer fertility treatment activity in Australia. The company continues to operate within the growing reproductive healthcare sector despite near-term industry challenges. Demand trends, demographic shifts and healthcare accessibility remain important themes shaping the sector. Monash IVF remains under the spotlight as industry activity trends and broader economic conditions influence Australia's fertility services market. ...
Highlights Monash IVF continues to face challenging operating conditions across the Australian fertility market. Recent market share improvements have provided a positive development amid broader sector pressures. Growth in international operations is emerging as an important area of focus. Monash IVF is showing signs of stabilisation through market share gains and international growth despite ongoing challenges across the fertility treatment sector. Australian healthcare stocks have experien...
Monash IVF (ASX:MVF) Rises on Another Profit Cut: Buy the Dip or Value Trap? Stocks Down Under
Monash IVF downgrades FY26 profit again as industry volumes fall Market Index

Almost two months after rejecting a $350 million takeover bid as undervaluing the company, Melbourne-based fertility group Monash IVF Group (ASX: MVF) has cut its full-year underlying net profit guidance due to a continued decline in Australian assisted reproductive technology (ART) cycle volumes. The company is now targeting net profit af...
Monash IVF (ASX:MVF) Rejects A$0.90 Soul Patts Bid: Shares Slide 6% on Second Knockback Stocks Down Under
other announcement

Highlights Revised takeover proposal places valuation under spotlight Consortium’s existing stake shapes ongoing discussions Board weighs certainty against long-term recovery outlook A renewed takeover proposal has brought Monash IVF Group Ltd (MVF) back into focus, with the board assessing improved terms while balancing near-term certainty against long-term growth prospects. A Fresh Bid Rekindles Market Attention The fertility services sector has re-entered the spotlight as Monas...
Monash IVF (ASX:MVF) Soul Patts-led bid jumps 12.5% to 90c, final offer Stocks Down Under
other announcement
other announcement
other announcement
other announcement